Every quarter Wall Street warns that Alphabet's AI spending will finally crack the business, and every quarter the company hands back a receipt that says otherwise. Here is why one investor keeps adding shares…
Covered-call ETFs are built to trade upside for income, so when one seems to deliver both at once, the obvious question is what the fund is hiding and whether the trade-off has simply been…
Apple just delivered its best June quarter ever, and the stock is up nearly 40% in a year, yet analyst upgrades are drying up and cost headwinds are quietly building. The bull and bear…
SCHG markets itself as a diversified large-cap growth fund, but a closer look at its holdings reveals a much narrower bet, and that structural quirk may explain why growth investors keep watching SPY and…
Vegas retirement budgets built on annual cost averages look solid until the July power bill arrives and reprices every assumption in the spreadsheet. Here is where the math actually breaks down.
She answered no to the blood thinner question and believed it. The insurer believed her pharmacy records instead, and those records remembered something she had long since forgotten.
A blowout jobs report pushed September rate hike odds past 60%, which should have hammered high-multiple chip stocks. Instead, the semiconductor complex ran straight into the headwind and left the rest of tech behind.
When tenants foot the bill for taxes, insurance, and maintenance, the landlord's job gets a lot simpler and the dividend check gets a lot more predictable. Three net lease REITs have quietly built some…
Memory stocks are surging into a rate-hike headwind that crushed the rest of the chip complex, and whether that split reflects a durable pricing cycle or an overstretched trade is the question every NAND…
Adobe named an internal successor days before a scheduled earnings report, and investors are not treating the timing as a coincidence. The question hanging over the stock is whether the new CEO can answer…
Gilead's quarterly dividend keeps growing and its HIV cash machine runs hot, but the whole enterprise depends on a single blockbuster drug with a patent expiration already penciled onto a calendar a decade out.…
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a…
UiPath stock is cratering despite beating Wall Street's revenue target, and the reason sitting inside the forward guidance explains why investors who rode a 29% rally into earnings are now racing for the exit.
Qualcomm has lost nearly a third of its value while its semiconductor peers surged, leaving one Wall Street analyst staking a reputation on a price target that towers over every other major forecast in…
Trump threatened to cut off trade with deficit countries if the Fed refuses to slash rates, citing a Supreme Court ruling that actually went against him, while his own Fed chair spent the previous…
